{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:21:13Z","timestamp":1761582073659,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijid.2021.03.060","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T14:03:39Z","timestamp":1617026619000},"page":"S78-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Bacille Calmette-Gu\u00e9rin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection \u2014 Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base"],"prefix":"10.1016","volume":"113","author":[{"given":"Jean B.","family":"Nachega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-7730","authenticated-orcid":false,"given":"Nadia A.","family":"Sam-Agudu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-2429","authenticated-orcid":false,"given":"Jeremiah","family":"Chakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0553-201X","authenticated-orcid":false,"given":"Patrick D.M.","family":"Katoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.ijid.2021.03.060_bib0005","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1073\/pnas.2016733117","article-title":"Lack of evidence for BCG vaccine protection from severe COVID-19","volume":"117","author":"Arlehamn","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.060_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2021.03.060_bib0015","unstructured":"Bacille Calmette-Guerin (BCG) Vaccine. (n.d.). Retrieved January 25, 2021, from https:\/\/www.precisionvaccinations.com\/vaccines\/bacille-calmette-guerin-bcg-vaccine."},{"issue":"October (6515)","key":"10.1016\/j.ijid.2021.03.060_bib0020","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.060_bib0025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41598-020-80787-z","article-title":"The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning","volume":"11","author":"Brooks","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.060_bib0030","first-page":"150","article-title":"Potential role of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in COVID-19 pandemic mortality: epidemiological and immunological aspects","volume":"38","author":"Charoenlap","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"12","key":"10.1016\/j.ijid.2021.03.060_bib0035","doi-asserted-by":"crossref","first-page":"e0243707","DOI":"10.1371\/journal.pone.0243707","article-title":"An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19","volume":"15","author":"Chimoyi","year":"2020","journal-title":"PLoS One"},{"year":"2021","series-title":"COVID-19 Vaccines","author":"Commissioner","key":"10.1016\/j.ijid.2021.03.060_bib0040"},{"key":"10.1016\/j.ijid.2021.03.060_bib0045","unstructured":"Coronavirus disease (COVID-19) \u2013 World Health Organization. (n.d.). Retrieved December 18, 2020, from https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"issue":"6","key":"10.1016\/j.ijid.2021.03.060_bib0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.17269\/s41997-020-00439-7","article-title":"Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective","volume":"111","author":"De Wals","year":"2020","journal-title":"Can J Public Health"},{"key":"10.1016\/j.ijid.2021.03.060_bib0055","article-title":"BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity","volume":"2020","author":"Eggenhuizen","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijid.2021.03.060_bib0060","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (6)","key":"10.1016\/j.ijid.2021.03.060_bib0065","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2021.03.060_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104187","article-title":"New disease old vaccine: is recombinant BCG vaccine an answer for COVID-19?","volume":"356","author":"Gupta","year":"2020","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ijid.2021.03.060_bib0075","unstructured":"Home\u2014ClinicalTrials.gov. (n.d.). Retrieved January 25, 2021, from https:\/\/clinicaltrials.gov\/ct2\/home."},{"issue":"1","key":"10.1016\/j.ijid.2021.03.060_bib0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s13063-020-04822-0","article-title":"BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Junqueira-Kipnis","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ijid.2021.03.060_bib0085","first-page":"1","article-title":"Re-reading ACT, BCG, and Low COVID-19 in Africa","author":"Kangbai","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.ijid.2021.03.060_bib0090","first-page":"1","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","author":"Kim","year":"2021","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ijid.2021.03.060_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jinf.2020.08.013","article-title":"Impact of routine infant BCG vaccination on COVID-19","volume":"81","author":"Kinoshita","year":"2020","journal-title":"J Infect"},{"issue":"July (3)","key":"10.1016\/j.ijid.2021.03.060_bib0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/vaccines8030378","article-title":"Significantly improved COVID-19 outcomes in countries with higher BCG vaccination coverage: a multivariable analysis","volume":"8","author":"Klinger","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.060_bib0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13312-020-1872-0","article-title":"Demystifying BCG vaccine and COVID-19 relationship","volume":"57","author":"Kumar","year":"2020","journal-title":"Indian Pediatrics"},{"issue":"7","key":"10.1016\/j.ijid.2021.03.060_bib0110","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/INF.0000000000002724","article-title":"Demand for BCG Vaccine due to unproven claims of its role in preventing COVID-19 is causing shortages of vaccines for infants in Japan","volume":"39","author":"Kuroda","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"9495","key":"10.1016\/j.ijid.2021.03.060_bib0115","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0140-6736(05)67535-6","article-title":"BCG: the story continues","volume":"366","author":"Lienhardt","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijid.2021.03.060_bib0120","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1073\/pnas.2016733117","article-title":"Lack of evidence for BCG vaccine protection from severe COVID-19","volume":"117","author":"Lindestam Arlehamn","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ijid.2021.03.060_bib0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/joim.13195","article-title":"Good old BCG \u2014 what a century-old vaccine can contribute to modern medicine","volume":"288","author":"Locht","year":"2020","journal-title":"J Int Med"},{"issue":"12","key":"10.1016\/j.ijid.2021.03.060_bib0130","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2020.1818522","article-title":"BCG vaccine: a hope to control COVID-19 pandemic amid crisis","volume":"16","author":"Malik","year":"2020","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"November","key":"10.1016\/j.ijid.2021.03.060_bib0135","first-page":"1","article-title":"Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19","author":"Mosaddeghi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.ijid.2021.03.060_bib0140","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"December (1)","key":"10.1016\/j.ijid.2021.03.060_bib0145","first-page":"152052","article-title":"BCG immunomodulation: from the \u2018hygiene hypothesis\u2019 to COVID-19","volume":"226","author":"Moulson","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijid.2021.03.060_bib0150","doi-asserted-by":"crossref","first-page":"25205","DOI":"10.1073\/pnas.2015234117","article-title":"The bacillus Calmette\u2013Gu\u00e9rin vaccination allows the innate immune system to provide protection from severe COVID-19 infection","volume":"117","author":"Patella","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ijid.2021.03.060_bib0155","first-page":"207","article-title":"Stop playing with data: there is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Ricc\u00f2","year":"2020","journal-title":"Acta Bio-Medica Atenei Parmensis"},{"key":"10.1016\/j.ijid.2021.03.060_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109689","article-title":"Routine childhood immunization may protect against COVID-19","volume":"140","author":"Salman","year":"2020","journal-title":"Med Hypotheses"},{"issue":"February (2)","key":"10.1016\/j.ijid.2021.03.060_bib0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urolonc.2020.09.031","article-title":"Bacillus Calmette-Guerin (BCG): its fight against pathogens and cancer","volume":"39","author":"Sfakianos","year":"2021","journal-title":"Urol Oncol"},{"issue":"0","key":"10.1016\/j.ijid.2021.03.060_bib0170","article-title":"The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials","volume":"0","author":"Singh","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.ijid.2021.03.060_bib0175","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1002\/cti2.1228","article-title":"Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Gu\u00e9rin vaccine: mechanisms, challenges and perspectives","volume":"9","author":"Sohrabi","year":"2020","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2021.03.060_bib0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13063-020-04389-w","volume":"21","author":"ten Doesschate","year":"2020","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.ijid.2021.03.060_bib0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2213-2600(15)00065-X","article-title":"L\u00e9on Charles Albert Calmette and Jean-Marie Camille Gu\u00e9rin","volume":"3","author":"Towey","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"15","key":"10.1016\/j.ijid.2021.03.060_bib0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17155589","article-title":"BCG vaccination and mortality of COVID-19 across 173 Countries: an ecological study","volume":"17","author":"Urashima","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2021.03.060_bib0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"issue":"December (12)","key":"10.1016\/j.ijid.2021.03.060_bib0200","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1002\/cti2.1227","article-title":"Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette-Gu\u00e9rin: potential for cross-reactive adaptive immunity","volume":"9","author":"Urb\u00e1n","year":"2020","journal-title":"Clin Transl Immunol"},{"issue":"41","key":"10.1016\/j.ijid.2021.03.060_bib0205","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1016\/j.vaccine.2020.08.018","article-title":"The effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: implications for the COVID-19 pandemic","volume":"38","author":"Yitbarek","year":"2020","journal-title":"Vaccine"},{"issue":"October (6515)","key":"10.1016\/j.ijid.2021.03.060_bib0210","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:49Z","timestamp":1761120289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"alternative-id":["S1201971221002794"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.060","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacille Calmette-Gu\u00e9rin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection \u2014 Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}